Using Suhexiang Pill for treating acute ischemic stroke
Suhexiang Pill for Acute Ischemic Stroke: A Prospective Registry Study of Real-world Data
Dongzhimen Hospital, Beijing · NCT05833932
This study is testing whether the Suhexiang Pill, a traditional Chinese medicine, can help people who have had an acute ischemic stroke feel better and recover safely.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Dongzhimen Hospital, Beijing (other) |
| Locations | 2 sites (Beijing, Beijing Municipality and 1 other locations) |
| Trial ID | NCT05833932 on ClinicalTrials.gov |
What this trial studies
This observational registry study aims to evaluate the effectiveness and safety of the Suhexiang Pill, a traditional Chinese medicine, in patients who have experienced an acute ischemic stroke. The study will enroll 1000 patients who have received this treatment within 7 days of symptom onset. By collecting real-world data, the study seeks to provide insights into the outcomes associated with Suhexiang Pill in this patient population.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have experienced an acute ischemic stroke within the last 7 days and have received Suhexiang Pill treatment.
Not a fit: Patients who are allergic to Suhexiang Pill, pregnant, or breastfeeding may not receive any benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide evidence supporting the use of Suhexiang Pill as a beneficial treatment option for patients with acute ischemic stroke.
How similar studies have performed: While traditional Chinese medicine has been used in various contexts, this specific approach with Suhexiang Pill for acute ischemic stroke is novel and lacks extensive prior evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Acute ischemic stroke within 7 days of symptom onset. * Age ≥ 18 * Patient who has received Suhexiang Pill treatment * Patient or legally authorized representative has signed informed consent. Exclusion Criteria: * Be allergic to Suhexiang Pill * Known to be pregnant or breastfeeding. * With conditions that render outcomes or follow-up unlikely to be assessed.
Where this trial is running
Beijing, Beijing Municipality and 1 other locations
- Dongzhimen Hospital — Beijing, Beijing Municipality, China (NOT_YET_RECRUITING)
- Dongzhimen Hospital — Beijing, Beijing Municipality, China (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Ischemic Stroke, acute ischemic stroke, traditional Chinese medicine, registry study